Based on research into the global and Chinese vaccine industries, Frost & Sullivan (Frost & Sullivan) has released a report on the global and Chinese vaccine markets, covering subjects including the Chinese vaccine market, HPV vaccine market, COVID-19 vaccine market, etc. The report predicts that the compound growth rates of the non-immunization-regulated vaccine market in China will reach 22.9% and 10.9% between 2020-2025 and 2025-2031, respectively. The report also analyzes the competitive situation of the Chinese HPV vaccine market, makes an in-depth comparison of major manufacturers and ongoing research pipelines, and predicts that the compound growth rates of the Chinese HPV vaccine market will reach 11.1% and 18.2% between 2020-2025 and 2025-2031.
If you need to purchase the full report, please contact us. You can send an email to PR@frostchina.com or call: 021-5407-5836.
